Hemopexin: a novel anti-inflammatory marker for distinguishing COPD from asthma
10.1016/j.physbeh.2021.113346 83 ZhangX.MaN.LingW.PangG.SunT.LiuJ.et al (2023)
Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinsons disease and other synucleinopathies
This explains why some patients experience: Temporary bloating or joint discomfort from fluid shifts Increased hunger due to ghrelin pathway activation Changes in blood sugar regulation in susceptible individuals Patients with diabetes, insulin resistance, or other metabolic conditions require medical evaluation and appropriate monitoring before and during treatment
Since m -Dys and OxS jointly contribute to both COVID-19 and PASC pathology, nutritional reset of virus-induced HMRD with NAC, glutamine, GSH, and antioxidant enzymes (i.e., SOD, catalase) could potentially resolve OxS and persistent pulmonary fibrotic sequelae in PASC patients 582
Bone 2005